Aeglea BioTherapeutics Reports Third Quarter 2021 Financial Results and Corporate Highlights

AUSTIN, Texas, Nov. 4, 2021 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (Nasdaq: AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeu…